EXACT Therapeutics AS
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
EXTX | OL
Overview
Corporate Details
- ISIN(s):
- NO0010852205 (+1 more)
- LEI:
- 2138006ZE5JAL39AGD55
- Country:
- Norway
- Address:
- Østre Aker vei 19, 0581 Oslo
- Website:
- https://www.exact-tx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing a technology platform for targeted therapeutic enhancement called Acoustic Cluster Therapy (ACT®). The company's vision is to become a leading precision medicine company by utilizing ultrasound to improve drug delivery in oncology. The proprietary ACT® platform uses a biomechanical mode of action to increase the uptake of co-administered drugs from blood vessels into the surrounding cancer tissue without damaging capillary walls. This technology is designed to be compatible with existing hospital ultrasound systems, requires no drug reformulation, and has shown potential in targeting tumors and crossing the blood-brain barrier. A key focus area is pancreatic cancer, with a clinical program in Phase 2 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-25 12:57 |
Investor Presentation
EXACT Therapeutics to present company update - Attachment: 251125 Exact Therap…
|
English | 1.5 MB | ||
| 2025-11-25 12:57 |
Report Publication Announcement
EXACT Therapeutics to present company update
|
English | 1.1 KB | ||
| 2025-11-24 08:25 |
Director's Dealing
EXACT Therapeutics AS: New option program and receipt of share options by prima…
|
English | 112.5 KB | ||
| 2025-11-24 08:25 |
Remuneration Information
EXACT Therapeutics AS: New option program and receipt of share options by prima…
|
English | 2.2 KB | ||
| 2025-09-25 08:00 |
Interim / Quarterly Report
EXACT Therapeutics first half 2025 interim results - Attachment: EXACT Therape…
|
English | 743.7 KB | ||
| 2025-09-25 08:00 |
Report Publication Announcement
EXACT Therapeutics first half 2025 interim results
|
English | 1.4 KB | ||
| 2025-09-18 08:00 |
Regulatory Filings
EXACT Therapeutics’ Phase 2 trial to be presented at the 2025 AACR Special Conf…
|
English | 2.0 KB | ||
| 2025-09-09 08:00 |
Regulatory Filings
EXACT Therapeutic’s Acoustic Cluster Therapy to be presented at the Ninth Inter…
|
English | 2.0 KB | ||
| 2025-08-12 08:30 |
Regulatory Filings
EXACT Therapeutics to Present at the European Society for Medical Oncology (ESM…
|
English | 1.8 KB | ||
| 2025-08-11 11:08 |
Report Publication Announcement
Financial calendar
|
English | 430 bytes | ||
| 2025-07-08 08:30 |
Legal Proceedings Report
EXACT Therapeutics announces grant of core patent in the U.S.
|
English | 1.9 KB | ||
| 2025-06-24 08:00 |
Regulatory Filings
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients w…
|
English | 3.0 KB | ||
| 2025-06-13 12:09 |
Director's Dealing
EXACT Therapeutics AS: Primary insider notification - Attachment: Notification …
|
English | 41.4 KB | ||
| 2025-06-13 12:09 |
Board/Management Information
EXACT Therapeutics AS: Primary insider notification
|
English | 1.3 KB | ||
| 2025-06-13 12:05 |
AGM Information
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 - Attachme…
|
Norwegian | 729.7 KB |
Automate Your Workflow. Get a real-time feed of all EXACT Therapeutics AS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EXACT Therapeutics AS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EXACT Therapeutics AS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
